Results · Apr-Jun 2026
Vista Pharmaceuticals Q1 FY27 results
Sales fell 100% to ₹0 crore from ₹1.5 crore in Apr-Jun 2025.
The net loss narrowed to ₹0.99 crore from ₹1.3 crore.
Against Jan-Mar 2026: loss narrows.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.0 | 1.5 | −100% |
| Operating profit (EBITDA) | -0.8 | -1.1 | n/m |
| Operating margin | - | −73.2% | - |
| Net profit | -1.0 | -1.3 | loss narrows |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.